StageZero Life Sciences Ltd. (SZLSF)
OTCMKTS · Delayed Price · Currency is USD
0.0190
+0.0010 (5.56%)
Aug 7, 2025, 3:28 PM EDT
AY Market Cap
StageZero Life Sciences has a market cap or net worth of $3.64 million as of August 8, 2025. Its market cap has decreased by -29.16% in one year.
Market Cap
3.64M
Enterprise Value
4.97M
Revenue
2.88M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.02
Market Cap Chart
Since January 2, 2001, StageZero Life Sciences's market cap has decreased from 5.07M to 3.64M, a decrease of -28.27%. That is a compound annual growth rate of -1.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 8, 2024 | 3.64M | -13.65% |
| Dec 28, 2023 | 4.21M | -6.41% |
| Dec 30, 2022 | 4.50M | -78.12% |
| Dec 31, 2021 | 20.57M | -42.45% |
| Dec 31, 2020 | 35.74M | 312.71% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 806.69M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 625.65M |
| Glass House Brands | 497.52M |
| Northwest Biotherapeutics | 366.75M |
| American Oncology Network | 353.52M |
| CytoDyn | 322.85M |